Clover Therapeutics discovers and develops precision medicines for diseases of aging with a genetics-driven approach. We have a genetically diverse, longitudinal, and re-contactable Medicare patient network with comprehensive clinical data as the foundation of our clinico-genomic studies. We are currently advancing preclinical drug programs in Age-related Macular Degeneration (AMD), and conducting two observational clinical studies in this disease.
Investors 3
| Date | Name | Website |
| - | MBC BioLab... | mbcbiolabs... |
| 20.07.2021 | Lifeforce ... | lifeforcec... |
| 11.08.2020 | Cantos Ven... | cantos.vc |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 10.07.2019 | Medicare A... | The two organizations will wor... | - | - | medcitynew... |
| - | Medicare A... | Medicare Advantage startup Clo... | - | - | medcitynew... |